Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-029411
Filing Date
2012-05-15
Accepted
2012-05-15 15:15:58
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v312839_10q.htm 10-Q 438790
2 EXHIBIT 10.1 v312839_ex10-1.htm EX-10.1 147585
3 EXHIBIT 10.2 v312839_ex10-2.htm EX-10.2 83168
4 EXHIBIT 31.1 v312839_ex31-1.htm EX-31.1 7071
5 EXHIBIT 31.2 v312839_ex31-2.htm EX-31.2 7071
6 EXHIBIT 32.1 v312839_ex32-1.htm EX-32.1 3773
7 EXHIBIT 32.2 v312839_ex32-2.htm EX-32.2 3690
  Complete submission text file 0001144204-12-029411.txt   2358491

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT arni-20120331.xml EX-101.INS 229109
9 XBRL TAXONOMY EXTENSION SCHEMA arni-20120331.xsd EX-101.SCH 15494
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20120331_cal.xml EX-101.CAL 35104
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20120331_def.xml EX-101.DEF 99194
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20120331_lab.xml EX-101.LAB 143367
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20120331_pre.xml EX-101.PRE 116470
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52153 | Film No.: 12843931
SIC: 2834 Pharmaceutical Preparations